Lactose intolerance
Conditions
Interventions
LFP group:Lactase + live bifidobacteria (Bifidobacteria bifidobacteria R0071, Infantium bifidobacteria R0033)
LFC group:Lactase + placebo (inactivated live bifidobacterium)
Sponsors
Chongqing Health Center for Women and Children
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Infants who visited Chongqing Maternal and Child Health Hospital and Maternal and Child Health Hospital of surrounding counties from November 2022 to November 2023 should be diagnosed with lactose intolerance by senior pediatrician or above.
Exclusion criteria
Exclusion criteria: a. The infant received probiotics or antibiotics from birth to enrollment; b. The infant has been fed supplementary food; c. Children with milk protein allergy or inflammatory bowel disease; d. Children suspected or diagnosed with neonatal necrotizing enterocolitis; e. Treatment with lactose free infant formula. f. The legal guardian refuses sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of diarrhea; | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of diarrhea;Galactorrhea frequency;Intestinal exhaust frequency;Frequency of crying;Fecal pH value;The amount of diapers used;Cost of economy;Lactose intake after 1 month; | — |
Countries
China
Contacts
Public ContactSun Hailan
Chongqing Health Center for Women and Children
Outcome results
None listed